Skip to content
Discover expert filmmaking tips, gear reviews, and tutorial…

Zimbabwe Declines ‘Unbalanced’ American Healthcare Assistance Package Over Information Fears

Medical funding image
The offered US financial assistance was aimed at initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has turned down a significant American healthcare agreement worth $367m (272 million pounds) over five years over Washington's demand for sensitive biological samples.

The decision came to light following a official document from December was leaked, indicating that Head of State Emmerson Mnangagwa believed the deal was "unbalanced".

An official spokesperson later clarified that the United States was demanding access to genetic material for research and commercial gain while was not willing to share the resulting advantages from future vaccines.

"We are forced to start the challenging and unfortunate process of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy noted the US had furnished over $1.9bn for health programmes to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has appealed for more dialogue to secure a deal agreeable to both sides so the nation's critical HIV treatment initiative can be sustained.

Wider Implications

Zimbabwe's decision follows a similar situation in neighbouring Kenya, where a court blocked a related health funding agreement after legal challenges were filed about the security of Kenyans' health data.

After resuming the presidency last year, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).

The agency had overseen aid for the American government, but Trump argued its spending was "wasteful" and his government was seeking government-to-government deals to boost transparency and responsibility.

As per reports, Sixteen African countries have to date signed similar agreements, representing over $18.3bn of fresh investment.

Specifics of the Declined Deal

The funds for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this cooperation might have yielded extraordinary advantages for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy via American-funded initiatives," Tremont said.

However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".

"Zimbabwe was being asked to share its biological resources and data for a long time, with no corresponding promise of access to any medical innovations – such as new medicines or tests – that might result from that shared data," he stated.

"Effectively, our nation would provide the raw materials for scientific discovery without any assurance that the resulting innovations would be accessible to our citizens should a new disease outbreak arise."

Sovereignty and Global Health

He also said that the American exit from the global health body and its pursuit of one-on-one deals were undermining frameworks already established through the global health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to manage potential global health emergencies.

"This system is designed to guarantee that when a nation provides its samples, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to develop them."

The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," he added.

"We encourage continued dialogue with our US partners on how subsequent co-operation might be designed in a manner that honours the independence and dignity of each country."

Medical Community Response

Medical experts stated it recognised the government's concerns, but urged that talks should continue given that a large portion of the country's HIV programmes relied on international support.

"If specific concerns arise, including those relating to information security or agreement terms, these can often be resolved through technical clarification and negotiated safeguards," it said.

The halted deal highlights the continuing challenges between accepting vital international aid and safeguarding local interests in an increasingly interconnected world.

DP
About the author

Debra Padilla

A seasoned filmmaker and writer with over 10 years of industry experience.

London Reel Center

Type to search articles.